BioControl Medical, Ltd

Results from Edwards Lifesciences Corp. 's PARTNER 2 transcatheter aortic valve replacement (TAVR) study will be presented at a late-breaking clinical trial session at the annual American College o

BioControl Medical Ltd. has terminated the INOVATE HF trial of its CardioFit vagus nerve stimulator (VNS) for the treatment of heart failure after a pre-specified interim analysis showed the t

Medtronic PLC has been one of the most acquisitive companies in recent years, clocking seven deals in 2014. And in spite of splashing a record $43 billion on Medtronic Minimally Invasive Therapies

The cardiology sector has long been one of the most innovative in medtech, with technologies such as drug-eluting stents (DES) and transcatheter aortic valves cutting down the need for more invasive o